This country code will remain if no action is taken to change it.
Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.
Development of bispecific antibodies and CAR-T cell therapies requires quantitative and reproducible bioassays for measuring T-cell activation. Choose a bioassay that measures CD3-mediated T-cell activation via the NFAT or IL-2 pathways.
Quantitative MOA-based bioassays for antibody functional characterization, potency and stability testing. Browse our portfolio of Fc Effector (ADCC, ADCP), Immune Checkpoint single-target (PD-1, CTLA-4, TIGIT, GITR, 4-1BB, OX40, CD40), combination (PD-1+TIGIT), and T-Cell Activation bioassays.
A full spectrum of protein characterization tools for biologics drug development. Browse our portfolio of antibody-specific (IdeS) and general (trypsin, Lys-C) proteases, glycosidases, protein purification and capture systems.